Dr. Bat graduated from Hacettepe University School of Medicine, Turkey in 2010 and then joined to NHLBI for post-doctoral training. After completion of 3 years of post-doctoral training, he completed internal medicine residency at NEOMED and experimental therapeutics fellowship at Cleveland Clinic. Subsequently he completed a hematology/oncology fellowship at Roswell Park Comprehensive Cancer Center, University at Buffalo. He focuses on bone marrow failure syndromes and has an interest on cytopenia, clonal hematopoiesis, hemostasis and thrombocytopenia. Dr. Bat is married and has 2 sons and 1 daughter. His interests outside of medicine are biking,cooking and travel with his family.


Medical School
Hacettepe University (2010)
Western Reserve Health Education (2016), Internal Medicine
Cleveland Clinic Foundation (2017), Experimental Medicine
University at Buffalo/Roswell Park Comprehensive Cancer Center (2020), Hematology Oncology

Research Interest

  • Bone Marrow Failure Syndromes
  • Cancer-related VTE
  • Clonal Hematopoiesis
  • Platelet Disorders


Featured Publications LegendFeatured Publications

Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients.
Welder D, Jeon-Slaughter H, Ashraf B, Choi SH, Chen W, Ibrahim I, Bat T, Br J Haematol 2021 Aug 194 3 530-536
Advanced Bladder Cancer Rechallenged With an Immune Checkpoint Inhibitor: A Case Report.
Bat T, Buck DA, Nathan R, Cinquino J, Sikorski M, Elefante A, Herbst L, Sule N, Fabiano A, George S, Urology 2019 Sep 131 24-26
Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria.
Clemente MJ, Przychodzen B, Hirsch CM, Nagata Y, Bat T, Wlodarski MW, Radivoyevitch T, Makishima H, Maciejewski JP, Leukemia 2018 11 32 11 2507-2511
The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy.
Bat T, Abdelhamid ON, Balasubramanian SK, Mai A, Radivoyevitch T, Clemente M, Maciejewski JP, Br. J. Haematol. 2018 09 182 5 730-733
Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms.
Balasubramanian SK, Aly M, Nagata Y, Bat T, Przychodzen BP, Hirsch CM, Adema V, Visconte V, Kuzmanovic T, Radivoyevitch T, Nazha A, Mukherjee S, Sekeres MA, Maciejewski JP, Leukemia 2018 02 32 2 550-553
Thrombopoietic status of patients on haemodialysis.
Bat T, Bat BE, El-Moghraby A, Patel S, Feng X, Dunbar CE, Sarac E, Br. J. Haematol. 2016 Mar 172 6 954-7
Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells.
Glait-Santar C, Desmond R, Feng X, Bat T, Chen J, Heuston E, Mizukawa B, Mulloy JC, Bodine DM, Larochelle A, Dunbar CE, Stem Cells 2015 Dec 33 12 3635-42
Human hematopoietic stem cells from mobilized peripheral blood can be purified based on CD49f integrin expression.
Huntsman HD, Bat T, Cheng H, Cash A, Cheruku PS, Fu JF, Keyvanfar K, Childs RW, Dunbar CE, Larochelle A, Blood 2015 Sep 126 13 1631-3
Colon sarcoidosis presenting with abdominal pain.
Bat T, Morgan CM, Marx R, Bailey RS, Endoscopy 2014 46 Suppl 1 UCTN E121
Active thrombopoiesis is associated with worse severity and activity of chronic GVHD.
Bat T, Steinberg SM, Childs R, Calvo KR, Barrett AJ, Battiwalla M, Baird K, Zhang D, Pulanic D, Dunbar CE, Pavletic SZ, Bone Marrow Transplant. 2013 Nov 48 12 1569-73

Honors & Awards

  • Thomas Frawley Fellowship Award
  • Edward P. Evans Fellowship
  • Intramural Research Training Award
    National Institutes of Health (2010)
  • Short-term Scientist Exchange Program Award

Professional Associations/Affiliations

  • American Association for Cancer Research (2020)
  • International Society of Thrombosis and Haemostasis (2020)
  • Hemostasis and Thrombosis Research Society (2019)
  • American Society of Clinical Oncology (2017)
  • American Society of Hematology (2016)